Abstract
Context: Primary hyperparathyroidism (PHPT), a leading cause of hypercalcemia and secondary osteoporosis, is underdiagnosed. Objective: This work aims to establish a foundation for an electronic medical record-based intervention that would prompt serum parathyroid hormone (PTH) assessment in patients with persistent hypercalcemia and identify care gaps in their management. Methods: A retrospective cohort study was conducted in a tertiary academic health system of outpatients with persistent hypercalcemia, who were categorized as having classic or normohormonal PHPT. Main outcome measures included the frequencies of serum PTH measurement in patients with persistent hypercalcemia, and their subsequent workup with bone mineral density (BMD) assessment, and ultimately, medical therapy or parathyroidectomy. Results: Among 3151 patients with persistent hypercalcemia, 1526 (48%) had PTH measured, of whom 1377 (90%) were confirmed to have classic (49%) or normohormonal (41%) PHPT. PTH was measured in 65% of hypercalcemic patients with osteopenia or osteoporosis (Pâ€
Author supplied keywords
Cite
CITATION STYLE
Dawood, N. B., Tseng, C. H., Nguyen, D. T., Yan, K. L., Livhits, M. J., Leung, A. M., & Yeh, M. W. (2021). Systems-Level Opportunities in the Management of Primary Hyperparathyroidism: An Informatics-based Assessment. Journal of Clinical Endocrinology and Metabolism, 106(12), E4993–E5000. https://doi.org/10.1210/clinem/dgab540
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.